Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moreau

Showing results (531-540 of 570) with videos related to

Pageof 57
Sort By:
Bone Marrow Transplantation|March 29, 2011
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantationZ Peric, X Cahu, P Chevallier, et al.
Bone Marrow Transplantation|June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapyS Vigouroux, N Milpied, J M Andrieu, et al.
Blood Cancer Journal|April 22, 2017
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatmentM A Dimopoulos, A K Stewart, T Masszi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2012
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceS Le Gouill, N Kröger, N Dhedin, et al.
Leukemia|April 16, 2014
Gene expression profile alone is inadequate in predicting complete response in multiple myelomaS B Amin, W-K Yip, S Minvielle, et al.
Leukemia|February 26, 2011
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantationZ Peric, X Cahu, P Chevallier, et al.
Leukemia|August 10, 2012
Minor clone provides a reservoir for relapse in multiple myelomaF Magrangeas, H Avet-Loiseau, W Gouraud, et al.
Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.
Scandinavian Journal of Immunology|September 9, 2015
Upregulation of Soluble HLA-G5 and HLA-G6 Isoforms in the Milder Histopathological Stages of Helicobacter pylori Infection: A Role for Subverting Immune Responses?D M B Oliveira Souza, J Genre, T G Alves Silva, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Pageof 57

Showing results (531-540 of 570) with videos related to

Sort By:
Pageof 57
Bone Marrow Transplantation|March 29, 2011
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantationZ Peric, X Cahu, P Chevallier, et al.
Bone Marrow Transplantation|June 12, 2002
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapyS Vigouroux, N Milpied, J M Andrieu, et al.
Blood Cancer Journal|April 22, 2017
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatmentM A Dimopoulos, A K Stewart, T Masszi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2012
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceS Le Gouill, N Kröger, N Dhedin, et al.
Leukemia|April 16, 2014
Gene expression profile alone is inadequate in predicting complete response in multiple myelomaS B Amin, W-K Yip, S Minvielle, et al.
Leukemia|February 26, 2011
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantationZ Peric, X Cahu, P Chevallier, et al.
Leukemia|August 10, 2012
Minor clone provides a reservoir for relapse in multiple myelomaF Magrangeas, H Avet-Loiseau, W Gouraud, et al.
Annals of Hematology|April 5, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomasB Tessoulin, P Thomare, E Delande, et al.
Scandinavian Journal of Immunology|September 9, 2015
Upregulation of Soluble HLA-G5 and HLA-G6 Isoforms in the Milder Histopathological Stages of Helicobacter pylori Infection: A Role for Subverting Immune Responses?D M B Oliveira Souza, J Genre, T G Alves Silva, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Pageof 57